Advertisement
Screener

ICU MEDICAL INC/DE (ICUI) Business Acquisition, Pro Forma Revenue

2.2 / 5 stars · 52/120 Roast Me

ICU MEDICAL INC/DE Business Acquisition, Pro Forma Revenue

ICU MEDICAL INC/DE (ICUI) reported Business Acquisition, Pro Forma Revenue of $1.72 billion for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-06.

Discontinued › Income Statement › Other Income

us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2023-11-06

  • ICU MEDICAL INC/DE business acquisition, pro forma revenue for the quarter ending 2023-09-30 was $597.53M, a 0.05% decline year-over-year.
  • ICU MEDICAL INC/DE business acquisition, pro forma revenue for the quarter ending 2022-12-31 was $1.70B, a 162.90% increase year-over-year.
  • ICU MEDICAL INC/DE business acquisition, pro forma revenue for the quarter ending 2022-09-30 was $597.86M, a 6.75% decline year-over-year.
  • ICU MEDICAL INC/DE business acquisition, pro forma revenue for the quarter ending 2022-06-30 was $561.00M, a 10.37% decline year-over-year.
  • ICU MEDICAL INC/DE business acquisition, pro forma revenue for fiscal 2022 was $2.30B, a 8.35% decline from fiscal 2021.
  • ICU MEDICAL INC/DE business acquisition, pro forma revenue for fiscal 2021 was $2.51B.
  • ICU MEDICAL INC/DE business acquisition, pro forma revenue for fiscal 2017 was $1.37M, a 3.17% decline from fiscal 2016.
  • ICU MEDICAL INC/DE business acquisition, pro forma revenue for fiscal 2016 was $1.42M.
Period endBusiness Acquisition, Pro Forma Revenue 3 monthBusiness Acquisition, Pro Forma Revenue 6 monthBusiness Acquisition, Pro Forma Revenue 6 month as first filedBusiness Acquisition, Pro Forma Revenue 9 monthBusiness Acquisition, Pro Forma Revenue 9 month as first filedBusiness Acquisition, Pro Forma Revenue 12 monthBusiness Acquisition, Pro Forma Revenue 12 month as first filed
2023-09-30$597.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06
$1.72B
10-Q · filed 2023-11-06
2023-06-30$1.12B
10-Q · filed 2023-08-07
2022-12-31$1.70B
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
$2.30B
derived: sum of 2 quarters · filed 2023-02-27
$2.86B
derived: sum of 3 quarters · filed 2023-02-27
$2.30B
10-K · filed 2023-02-27
2022-09-30$597.86M
10-Q · filed 2022-11-07
$1.16B
derived: sum of 2 quarters · filed 2022-11-07
$597.86M
10-Q · filed 2023-11-06
$1.72B
10-Q · filed 2022-11-07
$2.37B
derived: sum of 4 quarters · filed 2023-05-09
2022-06-30$561.00M
10-Q · filed 2022-08-09
$561.00M
10-Q · filed 2023-08-07
$1.12B
10-Q · filed 2022-08-09
$1.77B
derived: sum of 3 quarters · filed 2023-05-09
$2.41B
derived: sum of 4 quarters · filed 2023-05-09
2022-03-31$563.74M
10-Q · filed 2023-05-09
$1.21B
derived: sum of 2 quarters · filed 2023-05-09
$1.85B
derived: sum of 3 quarters · filed 2023-05-09
$2.48B
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31$647.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
$1.29B
derived: sum of 2 quarters · filed 2023-02-27
$1.91B
derived: sum of 3 quarters · filed 2023-02-27
$2.51B
10-K · filed 2023-02-27
2021-09-30$641.12M
10-Q · filed 2022-11-07
$1.27B
derived: sum of 2 quarters · filed 2022-11-07
$1.86B
10-Q · filed 2022-11-07
2021-06-30$625.94M
10-Q · filed 2022-08-09
$1.23B
10-Q · filed 2022-08-09
2021-03-31$594.14M
10-Q · filed 2022-05-09
2017-12-31$1.37M
10-K · filed 2020-03-02
$1.29M
10-K · filed 2018-03-16
2016-12-31$1.42M
10-K · filed 2019-03-01
$180.00K
10-K · filed 2018-03-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
Heartflow, Inc. (HTFL)United States$4.225B
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
HAEMONETICS CORP (HAE)United States$4.821B36.52
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
AtriCure, Inc. (ATRC)United States$3.089B
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55